Asoprisnil as a Novel Ligand Interacting with Stress-Associated Glucocorticoid Receptor
Ovinuchi Ejiohuo, Donald Bajia, Joanna Pawlak, Aleksandra Szczepankiewicz · 2024
Read Asoprisnil as a Novel Ligand Interacting with Stress-Associated Glucocorticoid Receptor by Ovinuchi Ejiohuo, Donald Bajia, Joanna Pawlak, Aleksandra Szczepankiewicz (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11726916.txt.
Description
Ovinuchi Ejiohuo and co-authors test whether a drug called asoprisnil can grip the body's stress hormone receptor in a useful way. That receptor, switched by cortisol, helps control the stress response, and its malfunction is tied to mental disorders. The standard blocker, mifepristone, carries drawbacks, so the team compared asoprisnil and two plant sterols against it using computer methods.
Docking simulations and motion simulations measured how firmly each candidate held the receptor and how the body would likely handle it. Asoprisnil was absorbed well in the gut, followed classic drug-likeness rules, and showed lower predicted toxicity than the standard drug. It also held the receptor most stably, with the strongest binding energy of the set. The authors propose it as a lead for stress-related mental illness drugs.
Catalog record
| CREATOR | Ovinuchi Ejiohuo, Donald Bajia, Joanna Pawlak, Aleksandra Szczepankiewicz |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |